Scarica l'app Stockscreener
0.2333
3.62%
0.00815
Precedente Chiudi:
$0.2251
Aprire:
$0.233
Volume 24 ore:
831.35K
Relative Volume:
0.09
Capitalizzazione di mercato:
$5.94M
Reddito:
$359.70K
Utile/perdita netta:
$-14.24M
Rapporto P/E:
-0.1424
EPS:
-1.6376
Flusso di cassa netto:
$-10.91M
1 W Prestazione:
+1.46%
1M Prestazione:
-18.16%
6M Prestazione:
-84.85%
1 anno Prestazione:
-86.90%
Intervallo 1D:
$0.2203
$0.236
Intervallo di 1 settimana:
$0.20
$0.236
Portata 52W:
$0.19
$2.045
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Nome
Biorestorative Therapies Inc
Settore
Industria
Telefono
(631) 760-8100
Indirizzo
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
0.2333 | 5.94M | 359.70K | -14.24M | -10.91M | -1.6376 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Biorestorative Therapies Inc Borsa (BRTX) Ultime notizie
BioRestorative Therapies Boosts Executive Compensation and Equity Incentives - TipRanks
BioRestorative (NASDAQ: BRTX) details 2025 executive pay and bonuses - Stock Titan
Biorestorative Therapies | EFFECT: Others - Moomoo
Biorestorative Therapies | 424B3: Prospectus - Moomoo
BioRestorative Therapies (NASDAQ: BRTX) registers 15.29M warrant shares - Stock Titan
BioRestorative to present clinical, preclinical data at ISCT - Investing.com UK
BioRestorative to present clinical, preclinical data at ISCT By Investing.com - Investing.com India
BioRestorative Therapies Presents New Data on MSC-Derived Programs at ISCT 2026 Annual Meeting - Quiver Quantitative
BioRestorative brings two programs to Dublin, including Phase 2 spine trial data - Stock Titan
Biorestorative Therapies, Inc. (BRTX) reports Q4 loss, lags revenue estimates - MSN
[EFFECT] BioRestorative Therapies, Inc. SEC Filing - Stock Titan
Here's why Biorestorative Therapies (BRTX) looks ripe for bottom fishing - MSN
Biorestorative Therapies | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filingmoomoo - Moomoo
BioRestorative Therapies (NASDAQ: BRTX) files S-1/A amendment; counsel opinion added - Stock Titan
Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing - Yahoo! Finance Canada
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates - MSN
BioRestorative Therapies (BRTX) price target decreased by 15.79% to 8.16 - MSN
BioRestorative prices $5M stock offering - MSN
BioRestorative Therapies Updates Corporate Presentation for Investors - The Globe and Mail
BioRestorative Therapies : Investor Presentation - marketscreener.com
BioRestorative Therapies updates corporate presentation, posts materials on website - TradingView
Updated BioRestorative (NASDAQ: BRTX) investor deck for conferences - Stock Titan
BRTX (BioRestorative Therapies Inc.) posts narrower Q4 2025 loss than consensus estimates, shares rise 2.61 percent in today's trading.Subscription Growth - Cổng thông tin điện tử tỉnh Tây Ninh
BioRestorative partners with dermatologist for clinical study By Investing.com - Investing.com India
BRTX Financials: Income Statement, Balance Sheet & Cash Flow | Biorestorative Therapies Inc - Stock Titan
BioRestorative partners with dermatologist for clinical study - Investing.com
BioRestorative Therapies, Inc. (BRTX) announces a strategic partnership with Dr. David J. Goldberg, a leading global authority in the field of dermatology. - Bitget
BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform - marketscreener.com
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading 5.7% HigherHere's Why - MarketBeat
Huge share increase and Nasdaq bid warning for BioRestorative (BRTX) - Stock Titan
Movement Recap: Is BioRestorative Therapies Inc stock a hidden gemDividend Hike & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Analyst Upgrade: Is BioRestorative Therapies Inc still a buy after recent gainsInsider Selling & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Biorestorative Therapies | DEF 14A: Definitive information statements - Moomoo
BioRestorative partners with 203 Creates for skincare brand launch - Investing.com Australia
BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform - Sahm
BioRestorative Therapies, Inc. Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform - marketscreener.com
BioRestorative partners with 203 Creates for skincare brand launch By Investing.com - Investing.com Canada
BioRestorative Therapies Announces Strategic Collaboration with 203 Creates - National Today
Biorestorative Therapies Inc Azioni (BRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):